Medications starting with

The drug is used to treat patients with metastatic colorectal cancer. It may be used as monotherapy or in combination with other drugs (e.g., 5-fluorouracil, folinic acid, bevacizumab, cetuximab, or capecitabine).

Dosage form: concentrate for infusion solution

ATC code: L01CE02

Manufacturer: Accord Healthcare Polska Sp. z o.o. Importer's Warehouse (Responsible for batch release)

The drug is used to treat advanced colorectal cancer. It may be used either alone or in combination with other drugs (e.g., 5-fluorouracil, folinic acid, cetuximab, bevacizumab, or capecitabine) depending on the stage of the disease and previous treatment.

Dosage form: concentrate for infusion solution

ATC code: L01CE02

Manufacturer: AkVida GmbH (batch control and batch release; bulk manufacturing, primary and secondary packaging, batch control)

The drug is used to treat patients with metastatic colorectal cancer. It may be prescribed as monotherapy or in combination with other drugs (e.g., 5-fluorouracil, folinic acid, cetuximab, bevacizumab, or capecitabine) depending on the stage of the disease and previous treatment.

Dosage form: concentrate for infusion solution

ATC code: L01XX19*

Manufacturer: Thymoorganon Pharmazie GmbH

The drug is intended for the treatment of advanced colorectal cancer. It is used both in combination with other drugs (5-fluorouracil, folinic acid, bevacizumab, cetuximab, or capecitabine) and as monotherapy if previous treatment has been ineffective.

Dosage form: concentrate for infusion solution

ATC code: L01CE02

Manufacturer: Medac Gesellschaft für klinische Spezialpräparate mbH (Manufacturer responsible for primary packaging labelling, secondary packaging, application of protective film (optional), batch control/testing and batch release)

The drug is used to treat patients with metastatic colorectal cancer. It may be used as monotherapy or in combination with other drugs (for example, 5-fluorouracil, folinic acid, bevacizumab, cetuximab, or capecitabine).

Dosage form: concentrate for infusion solution

ATC code: L01XX19

Manufacturer: Shilpa Medicare Limited (Full production cycle; Quality control and stability testing (physical and chemical tests))

The drug is used to treat patients with metastatic colorectal cancer. It may be prescribed as monotherapy or in combination with other drugs (e.g., 5-fluorouracil, folinic acid, bevacizumab, cetuximab, or capecitabine) depending on the stage and previous treatment.

Dosage form: concentrate for infusion solution

ATC code: L01CE02

Manufacturer: Venus Remedies Limited

The drug is used for the treatment of patients with metastatic colorectal cancer. It may be used both in combination with other drugs (e.g., 5-fluorouracil, folinic acid, bevacizumab, cetuximab, or capecitabine) and as monotherapy if previous treatment has been ineffective.

Dosage form: concentrate for infusion solution

ATC code: L01XX19

Manufacturer: Actavis Italia S.p.A.

The drug is used in ophthalmology for pupil dilation during diagnostic procedures, for the treatment and prevention of inflammation of the iris (iridocyclitis, anterior uveitis), as well as for the therapy of accommodation spasm and asthenopia in children.

Dosage form: drops, ophthalmic

ATC code: S01FB01

Manufacturer: Centiss Pharma Pvt. Ltd.

The drug is used for the treatment of metastatic colorectal cancer. It may be used either as monotherapy or in combination with other drugs (e.g., 5-fluorouracil, folinic acid, cetuximab, bevacizumab, or capecitabine) depending on the treatment regimen and the patient's previous experience.

Dosage form: concentrate for infusion solution

ATC code: L01CE02

Manufacturer: Hetero Labs Limited

The drug is used to treat patients with advanced colorectal cancer. It may be used either as monotherapy or in combination with other medicinal products (e.g., 5-fluorouracil, folinic acid, cetuximab, bevacizumab, or capecitabine) depending on the stage of the disease and previous treatment.

Dosage form: concentrate for infusion solution

ATC code: L01CE02

Manufacturer: Eugia Pharma Specialities Limited

The drug is used for the prevention and treatment of iron deficiency states, as well as iron deficiency anemias. It is also prescribed for the prevention of iron deficiency in children, pregnant women, the elderly, and those following a vegetarian diet.

Dosage form: solution, oral

ATC code: B03AB02

Manufacturer: PJSC "Biolik"

The drug is intended for the treatment of adults and children (weighing at least 25 kg) with HIV-1 infection in combination with other antiretroviral agents.

Dosage form: tablets, film-coated

ATC code: J05AJ01

Manufacturer: Merck Sharp & Dohme B.V. (primary and secondary packaging, batch release authorization)

The drug is indicated for the treatment of arterial hypertension (high blood pressure), particularly in cases where telmisartan monotherapy does not provide adequate blood pressure control.

Dosage form: tablets

ATC code: C09DA07

Manufacturer: Evertoxgen Life Sciences Limited

The drug is intended for the treatment of arterial hypertension (high blood pressure) if the use of telmisartan alone does not provide adequate blood pressure control.

Dosage form: tablets

ATC code: C09DA07

Manufacturer: Evertoxgen Life Sciences Limited

The drug is intended for the treatment of arterial hypertension (high blood pressure), especially if the use of telmisartan alone does not provide adequate blood pressure control.

Dosage form: tablets

ATC code: C09DA07

Manufacturer: Evertoxgen Life Sciences Limited

The drug is prescribed for adults for bowel cleansing before medical procedures, such as endoscopy, radiological examinations, or surgical operations. It is not intended for the treatment of constipation.

Dosage form: concentrate, oral solution

ATC code: A06AD10

Manufacturer: BOFUUR Ipsen Industries

The product is used for cough (including bronchitis), hoarseness of voice (laryngitis, pharyngitis), and as an adjunct therapy for bronchial asthma. It helps with throat dryness caused by dry air, nasal congestion, or during physical exercise. It can also be used for infection prevention and for vocal strain (e.g., in teachers or singers).

Dosage form: lozenges

ATC code: R02A

Manufacturer: Engelhard Arzneimittel GmbH & Co.KG (responsible for batch release, primary and secondary packaging)

The drug is used for cough (including bronchitis), hoarseness of voice (laryngitis, pharyngitis), as well as an adjunct treatment for bronchial asthma. It helps with vocal cord strain (e.g., in teachers or singers) and with mucous membrane dryness due to dry air, restricted nasal breathing, or physical exercise.

Dosage form: lozenges

ATC code: R02A

Manufacturer: Engelhard Arzneimittel GmbH & Co. KG (responsible for batch release, primary and secondary packaging)

The drug is used for the prevention of recurrent respiratory tract infections.

Dosage form: tablets, sublingual

ATC code: L03AX

Manufacturer: Bruschettini s.r.l.

The drug is used by adults for the treatment and prevention of angina attacks, in acute myocardial infarction, as well as in acute left ventricular heart failure.

Dosage form: spray, sublingual, metered-dose

ATC code: C01DA08

Manufacturer: LLC NPF "Mikrokhim" (production unit (all stages of the manufacturing process); responsible for batch release excluding control/testing of the batch)

The drug is used for the symptomatic treatment of unstable angina, long-term therapy of vasospastic angina, in acute left ventricular heart failure, and acute myocardial infarction.

Dosage form: concentrate for infusion solution

ATC code: C01DA08

Manufacturer: LLC NVP "Mikrokhim" (Responsible for batch release, excluding batch control/testing)

The drug is used for the prevention and treatment of angina attacks (including post-infarction angina), as well as for the treatment of chronic congestive heart failure (in combination with other appropriate medications).

Dosage form: tablets

ATC code: C01DA08

Manufacturer: NVF "Mikrokhim" LLC (production unit (all stages of the manufacturing process); manufacturer's legal address; responsible for batch release, excluding batch control/testing)

The drug is used for the prevention and treatment of angina attacks (including post-infarction angina), as well as for the treatment of chronic congestive heart failure (in combination with other appropriate medications).

Dosage form: tablets

ATC code: C01DA08

Manufacturer: LLC NPF "Mikrokhim" (production unit (all stages of the production process); manufacturer's legal address; responsible for batch release, excluding batch control/testing)

The drug is used to relieve and prevent angina attacks. To prevent an attack, it is recommended to take it before expected physical or emotional exertion.

Dosage form: tablets, sublingual

ATC code: C01DA08

Manufacturer: NPF Microkhim LLC (production unit (all stages of manufacturing process); responsible for batch release, excluding batch control/testing)

The drug is used for the prevention and treatment of complications of diabetes mellitus, such as damage to the blood vessels of the lower extremities, eyes (retinopathy, cataract), kidneys (nephropathy), nerves (polyneuropathy), as well as encephalopathy.

Dosage form: tablets

ATC code: A10XA

Manufacturer: Farmak JSC

The drug is used to perform general inhalation anesthesia (induction and maintenance of anesthesia during surgery).

Dosage form: vapor for inhalation, liquid

ATC code: N01AB06

Manufacturer: Piramal Pharma Limited

The drug is used by adults for the treatment and prevention of angina attacks, as well as in acute myocardial infarction and acute left ventricular heart failure.

Dosage form: spray, oromucosal

ATC code: C01DA08

Manufacturer: Aescica Pharmaceuticals GmbH (secondary packaging, quality control of primary packaging "in bulk", responsible for batch release)

The drug is used to treat tuberculosis caused by Mycobacterium tuberculosis.

Dosage form: tablets

ATC code: J04AC01

Manufacturer: Macleods Pharmaceuticals Limited

The drug is used for the treatment of tuberculosis caused by Mycobacterium tuberculosis.

Dosage form: tablets

ATC code: J04AC01

Manufacturer: Macleods Pharmaceuticals Limited

The drug is used to treat active forms of tuberculosis (in combination with other agents) or for the prevention and treatment of latent tuberculosis infection (as a monotherapy).

Dosage form: tablets

ATC code: J04AC01

Manufacturer: PJSC "Scientific and Production Center "Borshchahivskyy Chemical and Pharmaceutical Plant"

The drug is used to treat active forms of tuberculosis (in combination with other agents), as well as for the prevention and treatment of latent tuberculosis infection in individuals who have been in contact with infected persons.

Dosage form: tablets

ATC code: J04AC01

Manufacturer: PJSC "Scientific and Production Center "Borshchahivskyy Chemical and Pharmaceutical Plant"

Dosage form: syrup

ATC code: J04AC01

Manufacturer: Yuria-Pharm LLC

The drug is used for the treatment of tuberculosis caused by mycobacteria, as well as for its prevention. It is prescribed both as a monotherapy and in combination with other anti-tuberculosis agents.

Dosage form: tablets, dispersible

ATC code: J04AC01

Manufacturer: Oxalis Labs

The drug is used to treat active forms of tuberculosis (in combination with other agents), to treat latent tuberculosis infection, and for the prevention of tuberculosis in individuals who have been in contact with infected persons.

Dosage form: tablets

ATC code: J04AC01

Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»

The drug is used to treat all forms and locations of active tuberculosis in adults and children.

Dosage form: solution for injection

ATC code: J04AC01

Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»

The drug is used for the treatment of ischemic heart disease (including various types of angina pectoris), arrhythmias (such as supraventricular tachycardia, atrial flutter, or atrial fibrillation), and arterial hypertension.

Dosage form: tablets, film-coated

ATC code: C08DA01

Manufacturer: AbbVie Deutschland GmbH & Co. KG (manufacturing, packaging, quality control and batch release)

The drug is used to treat ischemic heart disease (stable, unstable, and vasospastic angina, post-infarction angina), arrhythmias (paroxysmal supraventricular tachycardia, atrial flutter, or atrial fibrillation), and arterial hypertension.

Dosage form: tablets, prolonged-release

ATC code: C08DA01

Manufacturer: AbbVie Deutschland GmbH & Co. KG (manufacturing, packaging, quality control and batch release)

The drug is used to restore water and electrolyte balance in cases of dehydration (due to vomiting, diarrhea, burns, or blood loss), shock states, and when a patient is unable to take fluids orally. It is also used as a solvent for other medications for intravenous administration.

Dosage form: solution for infusion

ATC code: B05BB01

Manufacturer: Subsidiary Enterprise "Farmatreyd"

The drug is used to relieve symptoms of functional dyspepsia (chronic gastritis), such as abdominal bloating, a feeling of fullness in the stomach, pain or discomfort in the upper abdomen, heartburn, nausea, vomiting, and loss of appetite.

Dosage form: tablets, film-coated

ATC code: A03FA07

Manufacturer: PRO.MED.CS Prague a.s. (full-cycle manufacturing)

The drug is used to relieve symptoms of functional dyspepsia (chronic gastritis), such as abdominal bloating, a feeling of early satiety, pain and discomfort in the upper abdomen, loss of appetite, heartburn, nausea, and vomiting.

Dosage form: tablets

ATC code: A03FA07

Manufacturer: Saneca Pharmaceuticals JSC

The drug is used to treat various fungal infections, including vulvovaginal candidiasis, pityriasis versicolor, dermatomycoses (fungal infections of the skin, feet, and hands), onychomycosis (nail infections), as well as systemic mycoses such as aspergillosis, candidiasis, cryptococcosis, and histoplasmosis.

Dosage form: capsules

ATC code: J02AC02

Manufacturer: Pharma Life LLC

The drug is used to treat various fungal infections, such as vulvovaginal candidiasis, pityriasis versicolor, dermatomycoses (fungus of the feet, hands, trunk), onychomycosis (nail fungus), as well as systemic mycoses (aspergillosis, candidiasis, cryptococcosis, histoplasmosis, and others).

Dosage form: capsules

ATC code: J02AC02

Manufacturer: Farmak JSC

The drug is used to treat various fungal infections, including vulvovaginal candidiasis, pityriasis versicolor, dermatomycoses (fungal infections of the skin, feet, and hands), onychomycosis (nail infections), as well as systemic mycoses (aspergillosis, candidiasis, cryptococcosis, histoplasmosis, etc.).

Dosage form: capsules

ATC code: J02AC02

Manufacturer: Marxans Pharma Ltd.

The drug is prescribed for the symptomatic treatment of chronic stable angina in adults, as well as to reduce the risk of cardiovascular events in patients with symptomatic chronic heart failure.

Dosage form: tablets, film-coated

ATC code: C01EB17

Manufacturer: Bafna Pharmaceuticals Ltd.

The drug is indicated for the symptomatic treatment of chronic stable angina pectoris in adults with ischemic heart disease, as well as for the treatment of chronic heart failure in adults.

Dosage form: tablets, film-coated

ATC code: C01EB17

Manufacturer: Bafna Pharmaceuticals Ltd

The drug is prescribed to adults for the symptomatic treatment of chronic stable angina (in ischemic heart disease and normal sinus rhythm) or for the treatment of chronic heart failure (NYHA class II-IV).

Dosage form: tablets, film-coated

ATC code: C01EB17

Manufacturer: Anorra Pharma Private Limited

The drug is prescribed to adults for the symptomatic treatment of chronic stable angina (with normal sinus rhythm and a heart rate of 70 bpm or higher), as well as for the treatment of chronic heart failure NYHA class II-IV.

Dosage form: tablets, film-coated

ATC code: C01EB17

Manufacturer: Anorra Pharma Private Limited

The drug is prescribed for the symptomatic treatment of chronic stable angina in adults, as well as to reduce the risk of cardiovascular events in patients with chronic heart failure (provided there is a normal sinus rhythm and a heart rate of no less than 70 bpm).

Dosage form: tablets, film-coated

ATC code: C01EB17

Manufacturer: Ind-Swift Limited

The drug is prescribed for the symptomatic treatment of chronic stable angina in adults, as well as for the treatment of chronic heart failure in patients with normal sinus rhythm and a heart rate of no less than 70 beats per minute.

Dosage form: tablets, film-coated

ATC code: C01EB17

Manufacturer: Ind-Swift Limited

The drug is prescribed for the treatment of symptoms of estrogen deficiency in women during the postmenopausal period (if menopause occurred more than a year ago), as well as for the prevention of bone loss.

Dosage form: tablets

ATC code: G03CX01

Manufacturer: Cenexi